Medications to manage HIV may impact renal function. This session reviews the current state of HIV progression and survivability, first-line drugs used to treat HIV, and the potential impact of these medications on renal function, such as kidney injury and HIV-associated nephropathy (HIVAN).

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/5/2023.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.

Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this activity, the learner will be able to successfully plan care for patients with CKD and HIV based on the knowledge of the relationship between HIV and kidney function.

Tory Ervin MSN, MPH, AAHIVS

Clinical Training Specialist, MATEC Michigan, Midwest AIDS Education and Training Center

Appearances